Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role ofCRTC1/MAML2Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma

21 Jan 2016

Abstract excerpt

IMPORTANCE: The CRTC1/MAML2 fusion transcript, which arises from the CRTC1/MAML2 translocation, is a molecular marker unique to mucoepidermoid carcinoma (MEC), the most common malignant tumor of the salivary gland. The extent to which the transcript influences disease features and patient survival is unclear. OBJECTIVE: To determine whether the CRTC1/MAML2 fusion transcript is associated with disease stage, tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ear and Head Tumors
Share to Neuroblastoma Research and Treatments
Share to Salivary Gland Tumors Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26796488
DOI: 10.1001/jamaoto.2015.3270

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role ofCRTC1/MAML2Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid CarcinomaPMID 26796488Read ↗

Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma.Semantic proximity Read ↗

Clinicopathological significance of the CRTC3–MAML2 fusion transcript in mucoepidermoid carcinomaSemantic proximity Read ↗

<i>MECT1-MAML2</i> Fusion Transcript Defines a Favorable Subset of Mucoepidermoid CarcinomaSemantic proximity Read ↗

Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3‐MAML2 fusions, and clinicopathological featuresSemantic proximity Read ↗

Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma.Semantic proximity Read ↗

Gene expression profiling analysis of CRTC1-MAML2 fusion oncogene-induced transcriptional program in human mucoepidermoid carcinoma cellsSemantic proximity Read ↗

The clinical outcome, pathologic spectrum, and genomic landscape of 454 cases of salivary mucoepidermoid carcinomaSemantic proximity Read ↗

The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinomaSemantic proximity Read ↗

A Reappraisal of the MECT1/MAML2 Translocation in Salivary Mucoepidermoid CarcinomasSemantic proximity Read ↗

Primary intraosseous mucoepidermoid carcinoma of the jaw: Reappraisal of The MD Anderson Cancer Center experienceSemantic proximity Read ↗

HER2 and EGFR gene copy number alterations are predominant in high-grade salivary mucoepidermoid carcinoma irrespective of MAML2 fusion status.Semantic proximity Read ↗

Prospective testing of mucoepidermoid carcinoma for the <i>MAML2</i> translocation: Clinical ImplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.